QuantumBio, Inc is accelerating the drug discovery efforts by providing pharmaceutical, biotechnology companies and life science research organizations a next generation of Computer-Assisted Molecular Modeling (CAMM) and Computer-Assisted Drug Design (CADD) solutions.

QuantumBio's CAMM/CADD software and data content is based on technology developed between 1995 and present first while at the Pennsylvania State University and then while at the University of Florida - Gainesville in the labs of Dr. Kenneth M. Merz, Jr., an international leader in the field of computational chemistry for drug discovery. These proprietary tools developed at the cost of scores of FTE years and millions of dollars at Penn State will enable scientists engaged in drug discovery to leverage the precision of quantum mechanical approaches to model interactions between proteins and small molecules.

Medicinal chemistry is an integrated part of the drug discovery process. Medicinal chemists discover and optimize new chemical entities (NCE) to ensure a portfolio of high quality proprietary drug candidates.

medchem

The ability to accurately analyze molecular interaction with proteins will dramatically increase the success rate to develop molecules that combine high selectivity for the biological target in the human body and suitable pharmacological characteristics.